Author

S.-W. Tsaih

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Organism:human· 2 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Assay:imaging· 1

Frequent Co-Authors

H. Rui· 2 shared A. Geethadevi· 1 shared A. Lemke· 1 shared A. R. Peck· 1 shared B. Riley-Gillis· 1 shared C. Ghosh· 1 shared D. Parashar· 1 shared E. King· 1 shared

Activity by Year

2020-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

H. Rui

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Machine Learning Reveals Genetic Modifiers of the Immune Microenvironment of Cancer

B. Riley-Gillis, S.-W. Tsaih, E. King, S. Wollenhaupt, J. Reeb, A. R. Peck, K. Wackman, A. Lemke, H. Rui, Z. Dezso, M. J. Flister

This paper uses machine learning to identify genetic modifiers of the immune microenvironment in breast cancer, prioritizing LSP1 and TLR1 as potential therapeutic targets.

iScience · Sep 1, 2023Peer-reviewedCancer Biology

RNA-binding protein FXR1 drives cMYC translation by mRNA circularization through eIF4F recruitment in ovarian cancer

J. George, Y. Li, D. Parashar, S.-W. Tsaih, P. Gupta, A. Geethadevi, I. Kadembari, C. Ghosh, Y. Sun, R. Ramchandran, J. S. Rader, H. Rui, M. Dey, S. Pradeep, P. Chaluvally-Raghavan

This study identifies FXR1 as a driver of cMYC translation through mRNA circularization and eIF4F recruitment in ovarian cancer, linking FXR1 amplification to poor prognosis.

bioRxiv · Jul 19, 2020 · PreprintCancer Biology